Company: DMAAR
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001213900-25-112096
Chunk: 18

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part I, Item 1
Chunk 18
---

     (305,179)
  
    Ordinary
    share issuance cost 
        
     (7,703,027)
  
    Plus: 

    Remeasurement
    of carrying value to redemption value 
        
     11,986,206 
  
    Ordinary
    shares subject to possible redemption, January 29, 2025 
     20,000,000  
    $201,000,000 
  
    Gross
    proceeds from exercise of over-allotment option 
     3,000,000  
     30,000,000 
  
    Less: 

    Proceeds
    allocated to Public Rights from exercise of over-allotment option 
        
     (446,700)
  
    Ordinary
    share issuance cost from exercise of over-allotment option 
        
     (1,047,367)
  
    Plus: 

    Exercise of over-allotment
    option 
        
     305,179 
  
    Remeasurement
    of carrying value to redemption value 
        
     2,924,356 
  
    Ordinary
    shares subject to possible redemption, March 31, 2025 
     23,000,000  
    $232,735,468 
  
    Plus: 

    Remeasurement
    of carrying value to redemption value 
        
     2,420,498 
  
    Ordinary
    shares subject to possible redemption, June 30, 2025 
     23,000,000  
    $235,155,966 
  
    Plus: 

    Remeasurement
    of carrying value to redemption value 
        
     2,448,266 
  
    Ordinary
    shares subject to possible redemption, September 30, 2025 
     23,000,000  
    $237,604,232 

Derivative
Financial Instruments

The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are
accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued
at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative